Searching…
Founded in 2011, Covis Pharma is a private equity backed global specialty pharmaceutical company that markets therapeutic solutions in 50+ countries, for patients with life-threatening conditions and chronic illnesses.
Covis’ patient assistance programs help patients get access to their therapy of choice. Please contact the COVIS Patient Assistance Program with any questions or for additional assistance.
Founded in 2011, Covis Pharma is a private equity backed global specialty pharmaceutical company that markets therapeutic solutions in 50+ countries, for patients with life-threatening conditions and chronic illnesses.
Mar 14, 2025 · With this acquisition, Covis is now a wholly-owned subsidiary of Azurity. This strategic acquisition reinforces Azurity’s leadership in branded pharmaceuticals, harnessing the complementary strengths of...
Founded in 2011, Covis Pharma is a private equity backed global specialty pharmaceutical company that markets therapeutic solutions in 50+ countries, for patients with life-threatening conditions and chronic illnesses.
Jan 5, 2022 · Covis, headquarter in Luxembourg, is a global specialty pharmaceutical company that markets therapeutic solutions for patients with life-threatening conditions and chronic illnesses.
Jan 31, 2022 · Covis Pharma Announces Positive Topline Results from the AVANT Phase 3 Clinical Trial Showing Significant Improvement in Patients with Moderate to Severe Stable COPD
I understand that Covis Pharma is providing sample product free of charge as indicated above for trial in new patients. I certify I am a licensed practitioner eligible to request, receive, prescribe and dispense these...
Covis Pharma is committed to enhancing healthcare provider expertise and patient education by supporting educational initiatives focused on respiratory therapeutic areas and diagnostic imaging.
Oct 25, 2022 · Covis Pharma, founded in 2011 and headquartered in Luxembourg, is a global specialty pharmaceutical company that markets therapeutic solutions for patients with life-threatening conditions and chronic i...
